Global Diabetes Drugs Competitive Landscape Professional Research Report 2024

Research Summary

Diabetes drugs, also known as antidiabetic medications, are pharmaceutical compounds used to manage blood sugar levels in individuals with diabetes. These drugs work through various mechanisms to either increase insulin production, improve insulin sensitivity, slow down carbohydrate absorption in the intestines, or enhance the effectiveness of insulin. There are different classes of diabetes drugs, including metformin, sulfonylureas, meglitinides, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 receptor agonists, and insulin. The choice of diabetes drug depends on factors such as the type of diabetes, its severity, individual medical history, and response to treatment. Diabetes drugs are essential tools in achieving glycemic control and preventing complications associated with unmanaged blood sugar levels in both type 1 and type 2 diabetes.

According to DIResearch's in-depth investigation and research, the global Diabetes Drugs market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Diabetes Drugs include Sanofi, AstraZeneca, Bayer, Biocon, Boehringer Ingelheim, Eli Lilly, Ganlee, Ginwa, Guangzhou Baiyun Mountain, Hisun Pharmacy, Hua Dong, Huadong Medicine, Jumpcan Pharmacy, KELUN, Merck, MSD, North China Pharmaceutical Group Corporation, Novartis, Sanofi, Novo Nordisk, SHIJIAZHUANG YILING PHARMACEUTICAL, Takeda, Taloph, Tianan Pharmaceutical, Tonghua DongBao, Wanbang Biopharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Diabetes Drugs. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Diabetes Drugs market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Diabetes Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Diabetes Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Diabetes Drugs Include:

Sanofi

AstraZeneca

Bayer

Biocon

Boehringer Ingelheim

Eli Lilly

Ganlee

Ginwa

Guangzhou Baiyun Mountain

Hisun Pharmacy

Hua Dong

Huadong Medicine

Jumpcan Pharmacy

KELUN

Merck

MSD

North China Pharmaceutical Group Corporation

Novartis

Sanofi

Novo Nordisk

SHIJIAZHUANG YILING PHARMACEUTICAL

Takeda

Taloph

Tianan Pharmaceutical

Tonghua DongBao

Wanbang Biopharmaceuticals

Diabetes Drugs Product Segment Include:

Insulin

DPP-4

GLP-1

SGLT-2

Diabetes Drugs Product Application Include:

Type 1 Diabetes

Type 2 Diabetes

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Diabetes Drugs Industry PESTEL Analysis

Chapter 3: Global Diabetes Drugs Industry Porter's Five Forces Analysis

Chapter 4: Global Diabetes Drugs Major Regional Market Size and Forecast Analysis

Chapter 5: Global Diabetes Drugs Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Diabetes Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Diabetes Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Diabetes Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Diabetes Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Diabetes Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Diabetes Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Diabetes Drugs Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Diabetes Drugs Market Overview

1.1 Product Definition and Statistical Scope

1.2 Diabetes Drugs Product by Type

1.2.1 Global Diabetes Drugs Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Insulin

1.2.3 DPP-4

1.2.4 GLP-1

1.2.5 SGLT-2

1.3 Diabetes Drugs Product by Application

1.3.1 Global Diabetes Drugs Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Type 1 Diabetes

1.3.3 Type 2 Diabetes

1.4 Global Diabetes Drugs Market Revenue Analysis (2019-2030)

1.5 Diabetes Drugs Market Development Status and Trends

1.5.1 Diabetes Drugs Industry Development Status Analysis

1.5.2 Diabetes Drugs Industry Development Trends Analysis

2 Diabetes Drugs Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Diabetes Drugs Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Diabetes Drugs Market Analysis by Regions

4.1 Diabetes Drugs Overall Market: 2023 VS 2024 VS 2030

4.2 Global Diabetes Drugs Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Diabetes Drugs Revenue and Market Share by Region (2019-2024)

4.2.2 Global Diabetes Drugs Revenue Forecast by Region (2025-2030)

5 Global Diabetes Drugs Market Size by Type and Application

5.1 Global Diabetes Drugs Market Size by Type

5.2 Global Diabetes Drugs Market Size by Application

6 North America

6.1 North America Diabetes Drugs Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Diabetes Drugs Market Size by Type

6.4 North America Diabetes Drugs Market Size by Application

6.5 North America Diabetes Drugs Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Diabetes Drugs Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Diabetes Drugs Market Size by Type

7.4 Europe Diabetes Drugs Market Size by Application

7.5 Europe Diabetes Drugs Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Diabetes Drugs Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Diabetes Drugs Market Size by Type

8.4 China Diabetes Drugs Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Diabetes Drugs Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Diabetes Drugs Market Size by Type

9.4 APAC (excl. China) Diabetes Drugs Market Size by Application

9.5 APAC (excl. China) Diabetes Drugs Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Diabetes Drugs Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Diabetes Drugs Market Size by Type

10.4 Latin America Diabetes Drugs Market Size by Application

10.5 Latin America Diabetes Drugs Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Diabetes Drugs Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Diabetes Drugs Market Size by Type

11.4 Middle East & Africa Diabetes Drugs Market Size by Application

11.5 Middle East & Africa Diabetes Drugs Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Diabetes Drugs Market Revenue by Key Manufacturers (2020-2024)

12.2 Diabetes Drugs Competitive Landscape Analysis and Market Dynamic

12.2.1 Diabetes Drugs Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Sanofi

13.1.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Sanofi Diabetes Drugs Product Portfolio

13.1.3 Sanofi Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 AstraZeneca

13.2.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 AstraZeneca Diabetes Drugs Product Portfolio

13.2.3 AstraZeneca Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Bayer

13.3.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Bayer Diabetes Drugs Product Portfolio

13.3.3 Bayer Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Biocon

13.4.1 Biocon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Biocon Diabetes Drugs Product Portfolio

13.4.3 Biocon Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Boehringer Ingelheim

13.5.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Boehringer Ingelheim Diabetes Drugs Product Portfolio

13.5.3 Boehringer Ingelheim Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Eli Lilly

13.6.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Eli Lilly Diabetes Drugs Product Portfolio

13.6.3 Eli Lilly Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Ganlee

13.7.1 Ganlee Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Ganlee Diabetes Drugs Product Portfolio

13.7.3 Ganlee Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Ginwa

13.8.1 Ginwa Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Ginwa Diabetes Drugs Product Portfolio

13.8.3 Ginwa Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Guangzhou Baiyun Mountain

13.9.1 Guangzhou Baiyun Mountain Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Guangzhou Baiyun Mountain Diabetes Drugs Product Portfolio

13.9.3 Guangzhou Baiyun Mountain Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Hisun Pharmacy

13.10.1 Hisun Pharmacy Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Hisun Pharmacy Diabetes Drugs Product Portfolio

13.10.3 Hisun Pharmacy Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Hua Dong

13.11.1 Hua Dong Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Hua Dong Diabetes Drugs Product Portfolio

13.11.3 Hua Dong Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Huadong Medicine

13.12.1 Huadong Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Huadong Medicine Diabetes Drugs Product Portfolio

13.12.3 Huadong Medicine Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Jumpcan Pharmacy

13.13.1 Jumpcan Pharmacy Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Jumpcan Pharmacy Diabetes Drugs Product Portfolio

13.13.3 Jumpcan Pharmacy Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 KELUN

13.14.1 KELUN Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 KELUN Diabetes Drugs Product Portfolio

13.14.3 KELUN Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 Merck

13.15.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Merck Diabetes Drugs Product Portfolio

13.15.3 Merck Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.16 MSD

13.16.1 MSD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 MSD Diabetes Drugs Product Portfolio

13.16.3 MSD Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.17 North China Pharmaceutical Group Corporation

13.17.1 North China Pharmaceutical Group Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.17.2 North China Pharmaceutical Group Corporation Diabetes Drugs Product Portfolio

13.17.3 North China Pharmaceutical Group Corporation Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.18 Novartis

13.18.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.18.2 Novartis Diabetes Drugs Product Portfolio

13.18.3 Novartis Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.19 Sanofi

13.19.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.19.2 Sanofi Diabetes Drugs Product Portfolio

13.19.3 Sanofi Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.20 Novo Nordisk

13.20.1 Novo Nordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.20.2 Novo Nordisk Diabetes Drugs Product Portfolio

13.20.3 Novo Nordisk Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.21 SHIJIAZHUANG YILING PHARMACEUTICAL

13.21.1 SHIJIAZHUANG YILING PHARMACEUTICAL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.21.2 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Product Portfolio

13.21.3 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.22 Takeda

13.22.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.22.2 Takeda Diabetes Drugs Product Portfolio

13.22.3 Takeda Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.23 Taloph

13.23.1 Taloph Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.23.2 Taloph Diabetes Drugs Product Portfolio

13.23.3 Taloph Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.24 Tianan Pharmaceutical

13.24.1 Tianan Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.24.2 Tianan Pharmaceutical Diabetes Drugs Product Portfolio

13.24.3 Tianan Pharmaceutical Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.25 Tonghua DongBao

13.25.1 Tonghua DongBao Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.25.2 Tonghua DongBao Diabetes Drugs Product Portfolio

13.25.3 Tonghua DongBao Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.26 Wanbang Biopharmaceuticals

13.26.1 Wanbang Biopharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.26.2 Wanbang Biopharmaceuticals Diabetes Drugs Product Portfolio

13.26.3 Wanbang Biopharmaceuticals Diabetes Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Diabetes Drugs Industry Chain Analysis

14.2 Diabetes Drugs Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Diabetes Drugs Typical Downstream Customers

14.4 Diabetes Drugs Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support